Get the Stockscreener App
11.41
2.06%
0.23
Evolent Health Inc Stock (EVH) Forecast
The Evolent Health Inc (EVH) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $22.26, representing a +95.05% increase from the current price of $11.41. The highest analyst price target is $23.87, and the lowest is $20.64.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month EVH Price Target
Average 24.16
(+111.71% Upside)
Is Evolent Health Inc (EVH) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 36.51 | Neutral |
| STOCH(9,6) | 30.15 | Neutral |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | -1.5048 | Buy |
| ADX(14) | 41.95 | Sell |
| William %R | -61.23 | Neutral |
| CCI(14) | -3.8621 | Neutral |
Buy: 1
Sell: 2
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
11.25
Buy
|
11.32
Buy
|
| MA20 |
11.67
Sell
|
12.16
Sell
|
| MA50 |
16.94
Sell
|
15.97
Sell
|
| MA100 |
22.53
Sell
|
19.62
Sell
|
| MA200 |
24.05
Sell
|
22.72
Sell
|
Buy: 2
Sell: 8
Neutral: 0
Summary: Sell
According to our latest analysis, EVH could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 10 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on EVH, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 36.51 indicates that EVH is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 30.15 indicates that EVH is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that EVH is oversold. This suggests that EVH price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 41.95 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -3.8621 indicates that EVH is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term EVH price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Evolent Health Inc financial reports and earnings history, Evolent Health Inc (EVH) stock could reach $40.52 by 2030, $101.75 by 2040 and $127.58 by 2050. See the projected annual prices until 2050 of the Evolent Health Inc stock below:
- Evolent Health Inc (EVH) is expected to reach an average price of $75.77 in 2035, with a high prediction of $76.38 and a low estimate of $69.28. This indicates an $564.09% rise from the last recorded price of $11.41.
- Evolent Health Inc (EVH) stock is projected to chart a bullish course in 2040, with an average price target of $101.52, representing an $789.79% surge from its current level. The forecast ranges from a conservative $95.11 to a sky-high $101.75.
- Our analysts predict Evolent Health Inc (EVH) to jump 915.22% by 2045, soaring from $115.24 to an average price of $115.84, potentially reaching $121.07. While $115.24 is the low estimate, the potential upside is significant.
- Evolent Health Inc (EVH) stock is expected to climb by 2050, reaching an average of $126.64, a $1,010% jump from its current level. However, a wide range of estimates exists, with high and low targets of $127.58 and $120.62, respectively, highlighting the market's uncertainty.
Evolent Health Inc Stock (EVH) Year by Year Forecast
Evolent Health Inc Stock (EVH) Price Forecast for 2025
Evolent Health Inc Stock (EVH) is expected to reach an average price of $24.16 in 2025, with a high prediction of $30.14 and a low estimate of $18.17. This indicates an +111.71% rise from the last recorded price of $11.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $23.21 | $20.64 | $23.87 | +103.38% |
| February, 2025 | $24.55 | $23.07 | $25.81 | +115.20% |
| March, 2025 | $23.43 | $23.28 | $26.53 | +105.33% |
| April, 2025 | $20.00 | $18.17 | $24.23 | +75.33% |
| May, 2025 | $21.25 | $19.12 | $21.32 | +86.23% |
| June, 2025 | $22.64 | $21.08 | $23.27 | +98.40% |
| July, 2025 | $21.54 | $20.47 | $24.86 | +88.78% |
| August, 2025 | $23.11 | $21.41 | $23.48 | +102.57% |
| September, 2025 | $28.62 | $23.13 | $28.92 | +150.80% |
| October, 2025 | $29.52 | $27.81 | $30.14 | +158.71% |
| November, 2025 | $28.31 | $27.11 | $29.83 | +148.14% |
| December, 2025 | $26.03 | $25.53 | $28.57 | +128.17% |
Evolent Health Inc Stock (EVH) Price Forecast for 2026
The predicted value for Evolent Health Inc (EVH) in 2026 is set at an average of $38.04. Estimates vary from a peak of $49.97 to a trough of $26.10, indicating an +233.37% surge from the present price of $11.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $31.44 | $26.10 | $31.49 | +175.53% |
| February, 2026 | $31.75 | $30.53 | $32.15 | +178.28% |
| March, 2026 | $34.22 | $31.33 | $34.66 | +199.88% |
| April, 2026 | $36.05 | $33.49 | $36.91 | +215.93% |
| May, 2026 | $37.63 | $34.32 | $39.14 | +229.81% |
| June, 2026 | $37.26 | $35.69 | $38.51 | +226.51% |
| July, 2026 | $37.23 | $34.87 | $39.33 | +226.27% |
| August, 2026 | $36.83 | $35.73 | $38.10 | +222.80% |
| September, 2026 | $40.38 | $36.66 | $40.70 | +253.93% |
| October, 2026 | $41.57 | $38.93 | $41.96 | +264.30% |
| November, 2026 | $42.46 | $40.41 | $42.87 | +272.14% |
| December, 2026 | $49.07 | $42.35 | $49.97 | +330.09% |
Evolent Health Inc Stock (EVH) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Evolent Health Inc (EVH) is $49.62, with a high forecast of $59.05 and a low forecast of $40.18. This indicates an +334.86% increase from the last price of $11.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $48.47 | $47.26 | $52.77 | +324.77% |
| February, 2027 | $47.29 | $45.55 | $49.22 | +314.46% |
| March, 2027 | $45.13 | $43.52 | $48.28 | +295.55% |
| April, 2027 | $44.11 | $40.49 | $46.85 | +286.56% |
| May, 2027 | $42.11 | $40.18 | $43.87 | +269.06% |
| June, 2027 | $46.62 | $41.15 | $47.31 | +308.61% |
| July, 2027 | $51.55 | $46.72 | $52.39 | +351.76% |
| August, 2027 | $47.42 | $46.87 | $52.26 | +315.59% |
| September, 2027 | $48.98 | $44.52 | $50.95 | +329.28% |
| October, 2027 | $47.01 | $45.95 | $52.01 | +311.96% |
| November, 2027 | $53.37 | $47.95 | $54.97 | +367.74% |
| December, 2027 | $55.02 | $48.57 | $59.05 | +382.22% |
Evolent Health Inc Stock (EVH) Price Forecast for 2028
In 2028, Evolent Health Inc (EVH) is projected to reach an average price of $51.30, with a high projection of $60.10 and a low estimate of $42.50. This indicates an +349.61% rise from the last price of $11.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $56.69 | $52.63 | $58.00 | +396.89% |
| February, 2028 | $56.33 | $54.28 | $60.10 | +393.68% |
| March, 2028 | $52.40 | $49.95 | $58.42 | +359.25% |
| April, 2028 | $48.33 | $42.50 | $52.62 | +323.61% |
| May, 2028 | $48.28 | $47.35 | $50.40 | +323.11% |
| June, 2028 | $51.92 | $46.04 | $53.44 | +355.04% |
| July, 2028 | $53.64 | $51.24 | $54.48 | +370.15% |
| August, 2028 | $52.42 | $51.79 | $57.66 | +359.39% |
| September, 2028 | $53.09 | $50.99 | $54.23 | +365.29% |
| October, 2028 | $55.75 | $52.02 | $58.44 | +388.64% |
| November, 2028 | $52.97 | $50.19 | $57.61 | +364.20% |
| December, 2028 | $52.39 | $49.61 | $54.57 | +359.15% |
Evolent Health Inc Stock (EVH) Price Forecast for 2029
The 2029 price forecast for Evolent Health Inc Stock (EVH) is $48.92 on average, with a high prediction of $58.70 and a low estimate of $39.13. This represents an +328.72% increase from the previous price of $11.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $52.67 | $50.58 | $53.84 | +361.62% |
| February, 2029 | $47.87 | $47.12 | $52.80 | +319.59% |
| March, 2029 | $48.79 | $47.44 | $49.05 | +327.60% |
| April, 2029 | $50.74 | $48.46 | $51.26 | +344.72% |
| May, 2029 | $50.93 | $46.15 | $51.68 | +346.40% |
| June, 2029 | $52.02 | $50.50 | $53.41 | +355.90% |
| July, 2029 | $56.27 | $48.13 | $56.95 | +393.18% |
| August, 2029 | $52.84 | $52.18 | $56.90 | +363.14% |
| September, 2029 | $57.66 | $52.60 | $57.66 | +405.33% |
| October, 2029 | $56.20 | $55.82 | $58.70 | +392.55% |
| November, 2029 | $53.44 | $52.99 | $57.13 | +368.39% |
| December, 2029 | $40.06 | $39.13 | $54.63 | +251.10% |
Evolent Health Inc Stock (EVH) Price Forecast for 2030
Evolent Health Inc Stock (EVH) is expected to reach an average price of $36.60 in 2030, with a high forecast of $41.05 and a low forecast of $32.16. This signifies an +220.78% surge from the last price of $11.41.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $33.94 | $33.89 | $40.52 | +197.50% |
| February, 2030 | $33.61 | $33.43 | $34.95 | +194.58% |
| March, 2030 | $32.95 | $32.75 | $34.11 | +188.77% |
| April, 2030 | $33.74 | $32.16 | $34.76 | +195.72% |
| May, 2030 | $34.53 | $33.06 | $35.54 | +202.64% |
| June, 2030 | $34.70 | $33.94 | $35.39 | +204.10% |
| July, 2030 | $38.45 | $34.68 | $38.56 | +236.96% |
| August, 2030 | $35.83 | $33.75 | $38.94 | +214.02% |
| September, 2030 | $38.48 | $35.73 | $38.74 | +237.27% |
| October, 2030 | $40.46 | $38.46 | $40.47 | +254.61% |
| November, 2030 | $34.67 | $34.42 | $41.05 | +203.85% |
| December, 2030 | $34.33 | $32.85 | $35.51 | +200.89% |
1.16%
0.30%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):